What is ProtoLytic?
ProtoLytic, LLC is at the forefront of accelerating medical claims processing through advanced AI technology. The company offers a suite of products designed to streamline operations for healthcare providers and insurance companies. Its Proto-Link product functions as a powerful analytics engine, providing data-driven recommendations based on medical treatment and reimbursement rules. Complementing this is UR Express, a solution that automates medical insurance case management and utilization review processes. These offerings can be seamlessly integrated into existing healthcare platforms or accessed via ProtoLytic's cloud-based services, addressing the critical need for enhanced efficiency in claims processing.
How much funding has ProtoLytic raised?
ProtoLytic has raised a total of $315K across 2 funding rounds:
Debt
$150K
Debt
$165K
Debt (2020): $150K with participation from PPP
Debt (2021): $165K led by PPP
Key Investors in ProtoLytic
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for ProtoLytic?
With substantial late-stage funding and a recent strategic investment, ProtoLytic is well-positioned for significant scaling and further product development. The company's focus on AI for medical claims processing aligns with the growing demand for digital transformation in healthcare. Future strategic moves are likely to involve expanding market reach, enhancing its AI capabilities, and potentially forging new partnerships within the healthcare ecosystem to further optimize claims management and reduce administrative burdens for providers and payers alike.
See full ProtoLytic company page
